Abstract
IntroductionMonoclonal antibodies (MAbs) are integral to manage Inflammatory Bowel Disease (IBD). At Brighton & Sussex University Hospital, intravenous MAbs, infliximab and vedolizumab, are administered in an outpatient setting. Licensing specifies...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have